ANIKA THERAPEUTICS, INC. (ANIK) SEC News June 23, 2026, 20:30 UTC 1 1 comments HENNEMAN JOHN B III 🟢 acquired 10.4K shares of Anika Therapeutics, Inc. (ANIK) Transaction Date: Jun 18, 2026 | Filing ID: 279542 Comment Full text
ANIKA THERAPEUTICS, INC. (ANIK) SEC News June 23, 2026, 20:30 UTC 1 1 comments Richard Stephen 🟢 acquired 10.4K shares of Anika Therapeutics, Inc. (ANIK) Transaction Date: Jun 18, 2026 | Filing ID: 279541 Comment Full text
STEALTHGAS INC. (GASS) SEC News June 23, 2026, 20:30 UTC 1 1 comments Jolliffe Michael 🟡 adjusted position in 0 shares (2 derivative) of StealthGas Inc. (GASS) at $6.43 Transaction Date: Jun 18, 2026 | Filing ID: 279540 Comment Full text
ANIKA THERAPEUTICS, INC. (ANIK) SEC News June 23, 2026, 20:30 UTC 1 1 comments Capper Joseph H 🟢 acquired 10.4K shares of Anika Therapeutics, Inc. (ANIK) Transaction Date: Jun 18, 2026 | Filing ID: 279539 Comment Full text
WORLD KINECT CORP (WKC) SEC News June 23, 2026, 20:30 UTC 1 1 comments STEBBINS PAUL H 🟢 acquired 6.1K shares of WORLD KINECT CORP (WKC) Transaction Date: Jun 18, 2026 | Filing ID: 000005 Comment Full text
ENOVA INTERNATIONAL, INC. (ENVA) SEC News June 23, 2026, 20:30 UTC 1 1 comments TEBBE MARK 🔴 sold 20.0K shares of Enova International, Inc. (ENVA) at $201.37 ($4.0M) Transaction Date: Jun 18, 2026 | Filing ID: 279537 Comment Full text
MONRO, INC. (MNRO) SEC News June 23, 2026, 20:30 UTC 1 1 comments Chang Kathryn M. 🔴 sold 637 shares of MONRO, INC. (MNRO) Transaction Date: Jun 13, 2026 | Filing ID: 279534 Comment Full text
GLAUKOS CORP (GKOS) SEC News June 23, 2026, 20:30 UTC 1 0 comments New Form 4/A - GLAUKOS Corp <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0001529196-26-000006 <b>Size:</b> 5 KB Comment Full text
ALLOGENE THERAPEUTICS, INC. (ALLO) SEC News June 23, 2026, 20:29 UTC 1 1 comments Director WITTE OWEN N. 🟢 acquired 95.4K shares (1 derivative) of Allogene Therapeutics, Inc. (ALLO) Transaction Date: Jun 18, 2026 | Filing ID: 000002 Comment Full text
VERA THERAPEUTICS, INC. (VERA) SEC News June 23, 2026, 20:29 UTC 1 1 comments 📋 MARSHALL FORDYCE (Director) plans to sell 74K shares of Vera Therapeutics, Inc. (at $38.43 each, total $2.8M) Filed: Jun 23, 2026 | ID: 006433 Comment Full text